The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Angle Receives GBP700,000 From Geomerics Sale Escrow Release

Tue, 22nd Dec 2015 11:45

LONDON (Alliance News) - Angle PLC on Tuesday said it has received about GBP700,000 in cash from the release of an escrow amount in relation to the sale of Geomerics in December 2013.

"As part of its refocus as a pure-play specialist medtech company to deploy all its resources on the Parsortix non-invasive cancer diagnostics business, ANGLE sold its investment in graphics technology developer Geomerics Ltd," the company said.

The sale generated GBP6.2 million for Angle, with GBP5.5 million of that received immediately and the remainder held in escrow to settle any valid claims.

"We are pleased that the Geomerics transaction has completed successfully and the full escrow amount has been released," Andrew Newland, founder and chief executive, said.

Shares in Angle were up 0.7% at 68.95 pence on Tuesday morning.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News
5 Jun 2024 16:32

EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

5 Jun 2024 10:08

Angle unveils plans to raise more than £10m

(Sharecast News) - Liquid biopsy specialist Angle is to raise more than £10m to support future growth, the UK company announced on Wednesday.

16 May 2024 20:09

TRADING UPDATES: Bens Creek considers administration; Nexxen inks deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

16 May 2024 11:46

Angle reports promising results from Parsortix study

(Sharecast News) - Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.